ArticleScientific reports2026
Impact of timely vaccination and genomic surveillance on controlling consecutive waves of SARS-CoV-2 variants.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
During the global COVID-19 pandemic, different SARS-CoV-2 variants of concern (VOCs) emerged, causing massive transmission waves that affected infection outcomes, economies and public health. From January to July 2021 in Uruguay, the transmission wave was primarily driven by the Gamma VOC amidst a largely immunologically naive population. Following the implementation of a nationwide vaccination campaign, the detection of the Delta VOC in July 2021 did not trigger a significant transmission wave, even in the face of increased mobility during the winter holidays (late June to mid-July). We present a comprehensive analysis of the dynamics of SARS-CoV-2 in Uruguay until September 2021. By analysing 1792 viral genomes, we integrate genomic data with vaccination records, variant surveillance and epidemiological information at both regional and global scales. Our study highlights the role of timely vaccination combined with real-time genomic surveillance programmes in effectively monitoring and mitigating critical phases of the COVID-19 epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.